Yesterday G-Therapeutics announced a huge funding. According to the press release management and development of the EPFL spin-off will be based in the Netherlands. We asked Sjaak Dekkers, CEO (picture), and co-founder Vincent Delattre about their plans for Lausanne and Eindhoven and the next steps for the company.
“G-Therapeutics will maintain a strong foothold in Lausanne”
Posted on 20.04.2016 in News